VOYA Investment Management
PSTX

VOYA Investment Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

VOYA Investment Management’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,042
Closed -$202K – 2760
2024
Q4 		$202K Sell
21,042
-3,903
-16% -$20.4K ﹤0.01% 2388
2024
Q3 		$71.3K Buy
24,945
+318
+1% +$984 ﹤0.01% 2723
2024
Q2 		$71.9K Buy
24,627
+2,120
+9% +$5.8K ﹤0.01% 2745
2024
Q1 		$71.8K Sell
22,507
-48,291
-68% -$161K ﹤0.01% 2684
2023
Q4 		$238K Buy
70,798
+42,769
+153% +$110K ﹤0.01% 2480
2023
Q3 		$66.7K Hold
28,029
– – ﹤0.01% 2818
2023
Q2 		$49.3K Buy
+28,029
New +$71.6K ﹤0.01% 2900
2022
Q2 		– Sell
-11,437
Closed -$51K – 2914
2022
Q1 		$51K Hold
11,437
– – ﹤0.01% 2591
2021
Q4 		$78K Sell
11,437
-2,376
-17% -$16.2K ﹤0.01% 2700
2021
Q3 		$101K Sell
13,813
-99,924
-88% -$857K ﹤0.01% 2737
2021
Q2 		$1.14M Sell
113,737
-3,299
-3% -$29.5K ﹤0.01% 1548
2021
Q1 		$1.12M Sell
117,036
-136,124
-54% -$1.34M ﹤0.01% 1523
2020
Q4 		$2.78M Sell
253,160
-23,816
-9% -$251K 0.01% 1006
2020
Q3 		$2.46M Buy
+276,976
New +$3.15M 0.01% 952

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

VOYA Investment Management's PSTX Position: Q1 2025 in Review

VOYA Investment Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 21,042 shares — an estimated $202K sold.

VOYA Investment Management first reported a position in PSTX in Q3 2020 and held it in 14 quarters. The position peaked at $2.78M in Q4 2020. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • VOYA Investment Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • VOYA Investment Management sold 21,042 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $202K.
  • VOYA Investment Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • VOYA Investment Management's Poseida Therapeutics, Inc. Common Stock position peaked at $2.78M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on VOYA Investment Management's 13F filing for Q1 2025, filed 15 May 2025.